AMSTERDAM — A once daily, 50 mg dose of efruxifermin reduced fibrosis at 96 weeks in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH) compared with ...

Living within a mile of a golf course is associated with a 126% increased risk for Parkinson’s disease possibly due to ...

Learning your risk for Alzheimer’s disease through amyloid PET imaging does not appear to lead to emotional distress but may ...

Once-monthly efimosfermin alfa prescribed for metabolic dysfunction–associated steatohepatitis with F2 and F3 fibrosis ...

After pain, nausea and vomiting are the most documented symptoms in patients with cancer preceding unplanned acute care ...

A novel investigational endoscopic procedure targeting the duodenum appears beneficial in improving glycemic parameters in ...

Despite a risk for severe side effects, pembrolizumab has a record of improving recurrence-free survival that makes it an appealing treatment for advanced melanoma.

Short-interval CT imaging is a safe and cost-effective strategy for focal indeterminate consolidation in lung cancer ...

Young men growing up with mothers physically abused by partners are more likely than young women to commit partner violence, ...

Non-invasive biomarkers and scoring systems show strong capability in differentiating chronic liver disease from cirrhosis, ...

Multiple factors have a generation of medical students and young physicians struggling with mental health like never before.

Summer brings unique challenges for patients with COPD. Learn how rising temperatures and humidity affect symptoms and what ...